Skip to main content
Caplight Logo









IctioBiotic

IctioBiotic

Private
SantiagoHealthcare & Life Scienceshttps://ictiobiotic.com/

Last Round

Accelerator

Dec 1, 2018

Total Funding Raised

$114,500

Momentum

Top 25%

of companies Caplight tracks

Company Overview

IctioBiotic is a biotechnology company that develops oral biotherapeutics, such as probiotics, to improve the health of fish farms and reduce the use of antibiotics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

aquaculture probioticsimmunostimulantsfish feed additiveaquatechantibiotic alternativeoral biotherapeuticssalmon farmingfish health managementsustainable aquaculturefunctional feedSalmon Rickettsial SyndromeSRSmicrobial platformshrimp aquaculturetilapia aquaculture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IctioBiotic Comparables

Compare IctioBiotic with similar companies based on industry and business-model similarity.

IctioBiotic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aquit
92%
Nordly Holding AS
71%
Proteon Pharmaceuticals
70%

IctioBiotic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorDec 1, 2018

Key People

Founding team and executive leadership

Mario Tello Reyes

Chief Scientific Officer Co-founder

Founding Team

Geraldine Mlynarz

Co-Founder & CEO

Founding Team

Debbie Weinstein Szalachman

CFO

Executive Team

Camila Wilkens

COO

Executive Team

IctioBiotic Investors

Notable investors and investment history

IctioBiotic investors
InvestorRounds
Hatch BlueAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors grew 451% MoM, from 59 to 325.

  • Jan 8, 2026

    Monthly visitors grew 2268% MoM, from 31 to 734.

IctioBiotic Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

IctioBiotic Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about IctioBiotic's valuation, stock price, and market status.

Firmographic Details

HeadquartersSantiago
Employee Range6
Year Founded2018
Last FundingDec 1, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?